LipocineLPCN
13F holders, Q2 2024 (June 30)19holders +1
4new positions
3sold out
1famous investor
$8.24avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding Lipocine Inc. (LPCN) in their 13F filings, up 1 from Q1 2024. 4 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($1.8M), BlackRock Inc. ($736K) and UBS Group AG ($463K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lipocine Inc.
- CUSIP
- 53630X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $207K |
| Exits | 3 | $587 |
All 13F filers, Q1 2024 → Q2 2024: 106,684 shares bought and 48,950 shares sold, net +57,734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Vanguard Group Inc. | 0.00% | No change | 221,459 | $1.8M |
| BlackRock Inc. | 0.00% | Add +19.8% | 89,272 | $736K |
| UBS Group AG | 0.00% | Add +12944.3% | 56,221 | $463K |
| Geode Capital Management, LLC | 0.00% | Add +8.8% | 53,179 | $438K |
| Renaissance Technologies | 0.00% | Add +21.8% | 25,697 | $212K |
| Susquehanna International Group, LLP | 0.00% | Reduce -58.1% | 25,001 | $206K |
| State Street Corp. | 0.00% | No change | 18,626 | $153K |
| Northern Trust Corp. | 0.00% | New | 13,160 | $108K |
| Two Sigma Advisers, LP | 0.00% | Reduce -50.1% | 12,822 | $106K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,870 | $98K |
| Morgan Stanley | 0.00% | Add +264.8% | 2,634 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -61.7% | 772 | $6K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 471 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +233.8% | 227 | $2K |
| Clearstead Advisors, LLC | 0.00% | New | 74 | $610 |
| Tidemark, LLC | 0.00% | No change | 59 | $486 |
| Bank of America Corp. | 0.00% | New | 44 | $363 |
| Group One Trading LLC | 0.00% | Reduce -60.0% | 16 | $132 |
| Royal Bank of Canada | 0.00% | Reduce -35.7% | 9 | $0 |
"% of holder's portfolio" is LPCN's weight in each manager's 13F, not the share of Lipocine Inc. the manager owns.